<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33880611</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Respiratory parameters on diagnostic sleep studies predict survival in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>4321</StartPage><EndPage>4331</EndPage><MedlinePgn>4321-4331</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10563-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In amyotrophic lateral sclerosis (ALS), respiratory muscle involvement and sleep-disordered breathing relate to worse prognosis. The present study investigated whether respiratory outcomes on first-ever sleep studies predict survival in patients with ALS, specifically taking into account subsequent initiation of non-invasive ventilation (NIV).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From patients with ALS, baseline sleep study records, transcutaneous capnometry, early morning blood gas analysis, survival data and clinical disease characteristics were retrospectively analyzed. Patients were stratified according to whether enduring NIV was consecutively established ("NIV(+)") or not ("NIV(-)").</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the study cohort (n&#x2009;=&#x2009;158, 72 female, 51 with bulbar onset ALS, 105 deceased) sleep-disordered breathing was present at baseline evaluation in 97 patients. Early morning base excess (EMBE)&#x2009;&gt;&#x2009;2&#xa0;mmol/l predicted nocturnal hypercapnia. Ninety-five patients were NIV(+) and 63 were NIV(-). Survival from baseline sleep studies was significantly reduced in NIV(-) but not in NIV(+) patients with nocturnal CO<sub>2</sub> tension&#x2009;&#x2265;&#x2009;50&#xa0;mmHg, apnea hypopnea index&#x2009;&#x2265;&#x2009;5/h, and EMBE&#x2009;&gt;&#x2009;2&#xa0;mmol/l. Hazard ratio for EMBE&#x2009;&gt;&#x2009;2&#xa0;mmol/l was increased in NIV(-) patients only, and EMBE independently predicted survival in both NIV(-) and NIV(+) patients. Furthermore, EMBE on baseline sleep studies was the only predictor for survival from symptom onset, and hazard ratio for shorter survival was markedly higher in the NIV(-) than the NIV(+) group (2.85, p&#x2009;=&#x2009;0.005, vs. 1.71, p&#x2009;=&#x2009;0.042).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In patients with ALS, EMBE&#x2009;&gt;&#x2009;2&#xa0;mmol/l predicts nocturnal hypercapnia and shorter survival. Negative effects of sleep-disordered breathing on survival are statistically abolished by sustained NIV.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmle</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Park Reithofpark, Bad Feilnbach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xe4;ger</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, UKM Marienhospital Steinfurt, Steinfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boentert</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6133-1397</Identifier><AffiliationInfo><Affiliation>Department of Neurology with Institute of Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany. matthias.boentert@ukmuenster.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, UKM Marienhospital Steinfurt, Steinfurt, Germany. matthias.boentert@ukmuenster.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Base ecxess</Keyword><Keyword MajorTopicYN="N">Nocturnal hypercapnia</Keyword><Keyword MajorTopicYN="N">Non-invasive ventilation</Keyword><Keyword MajorTopicYN="N">Sleep-disordered breathing</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>MB and PY have received speaker honoraria and financial research support from Loewenstein Medical, Bad Ems, Germany. All other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33880611</ArticleId><ArticleId IdType="pmc">PMC8505303</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10563-0</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10563-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen X, Zheng Z, et al. The predictors of survival in Chinese amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Front Degener. 2015 doi: 10.3109/21678421.2014.993650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.993650</ArticleId><ArticleId IdType="pubmed">25581512</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33&#x2013;37. doi: 10.1136/jnnp.2007.118018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.118018</ArticleId><ArticleId IdType="pubmed">17550991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil J, Funalot B, Verschueren A, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245&#x2013;1251. doi: 10.1111/j.1468-1331.2008.02307.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02307.x</ArticleId><ArticleId IdType="pubmed">18973614</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Lo Re M, Piccoli T, et al. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122:217&#x2013;223. doi: 10.1111/j.1600-0404.2009.01290.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2009.01290.x</ArticleId><ArticleId IdType="pubmed">20078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepers S, van den Berg JP, Kalmijn S, et al. Effect of non-invasive ventilation on survival, quality of life, respiratory function and cognition: a review of the literature. Amyotroph Lateral Scler. 2006;7:195&#x2013;200. doi: 10.1080/14660820500514974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820500514974</ArticleId><ArticleId IdType="pubmed">17127557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleopa KA, Sherman M, Neal B, et al. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82&#x2013;88. doi: 10.1016/S0022-510X(99)00045-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00045-3</ArticleId><ArticleId IdType="pubmed">10385053</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Montini A, Lunetta C, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018 doi: 10.1111/ene.13547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13547</ArticleId><ArticleId IdType="pubmed">29266547</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger KI, Rapoport DM, Ayappa I, Goldring RM. Pathophysiology of hypoventilation during sleep. Sleep Med Clin. 2014;9:289&#x2013;300. doi: 10.1016/j.jsmc.2014.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsmc.2014.05.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Boentert M, Glatz C, Helmle C, et al (2017) Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 10.1136/jnnp-2017-316515</Citation><ArticleIdList><ArticleId IdType="pubmed">29054915</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Ringer TM, Wullenkord K, et al. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry. 2016;87:1022&#x2013;1026. doi: 10.1136/jnnp-2015-312185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312185</ArticleId><ArticleId IdType="pmc">PMC5013137</ArticleId><ArticleId IdType="pubmed">27010615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Turkman A, Pinto A, et al. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: The role of phrenic nerve studies. Clin Neurophysiol. 2009 doi: 10.1016/j.clinph.2009.02.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2009.02.170</ArticleId><ArticleId IdType="pubmed">19342290</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, et al. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. 2017 doi: 10.1186/s12931-017-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-017-0624-8</ArticleId><ArticleId IdType="pmc">PMC5526316</ArticleId><ArticleId IdType="pubmed">28743265</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta VN, Carrat&#xf9; P, Damiani MF, et al. The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis. 2016 doi: 10.1159/000447560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447560</ArticleId><ArticleId IdType="pubmed">27595268</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Lunetta C, et al. Factors predicting survival in ALS: a multicenter Italian study. J Neurol. 2017 doi: 10.1007/s00415-016-8313-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8313-y</ArticleId><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan RK, McNally S, Alexander M, et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005 doi: 10.1164/rccm.200403-314OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200403-314OC</ArticleId><ArticleId IdType="pubmed">15516537</ArticleId></ArticleIdList></Reference><Reference><Citation>Gay PC, Westbrook PR, Daube JR, et al. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc. 1991 doi: 10.1016/S0025-6196(12)62080-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-6196(12)62080-1</ArticleId><ArticleId IdType="pubmed">2072756</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Torrieri MC, Moglia C, et al (2020) The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring. J Neurol Neurosurg Psychiatry. 10.1136/jnnp-2020-323810</Citation><ArticleIdList><ArticleId IdType="pubmed">32605931</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges M, Attali V, Golmard JL, et al. Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation. J Neurol Neurosurg Psychiatry. 2016 doi: 10.1136/jnnp-2015-312606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312606</ArticleId><ArticleId IdType="pubmed">27090433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogna A, Nardi J, Prigent H, et al. Prognostic value of initial assessment of residual hypoventilation using nocturnal capnography in mechanically ventilated neuromuscular patients: a 5-year follow-up study. Front Med. 2016 doi: 10.3389/fmed.2016.00040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2016.00040</ArticleId><ArticleId IdType="pmc">PMC5020068</ArticleId><ArticleId IdType="pubmed">27679799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Bermejo J, Morelot-Panzini C, Arnol N, et al. Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study. Amyotrophic Lateral Scler Frontotemp Degener. 2013;14:373&#x2013;379. doi: 10.3109/21678421.2013.776086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.776086</ArticleId><ArticleId IdType="pubmed">23527531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria&#x2014;2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry RB Gamaldo CE, Harding SM, Lloyd RM, Marcus CL and Vaughn BV for the American Academy of Sleep Medicine BR (2015) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2</Citation></Reference><Reference><Citation>Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: Update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med. 2012 doi: 10.5664/jcsm.2172.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.2172</ArticleId><ArticleId IdType="pmc">PMC3459210</ArticleId><ArticleId IdType="pubmed">23066376</ArticleId></ArticleIdList></Reference><Reference><Citation>Windisch W, Walterspacher S, Siemon K, et al. Guidelines for non-invasive and invasive mechanical ventilation for treatment of chronic respiratory failure. Published by the German Society for Pneumology (DGP) Pneumologie. 2010;64:640&#x2013;652. doi: 10.1055/s-0030-1255558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1255558</ArticleId><ArticleId IdType="pubmed">20799159</ArticleId></ArticleIdList></Reference><Reference><Citation>Windisch W, Dreher M, Geiseler J, et al. Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure1update 2017. Pneumologie. 2017 doi: 10.1055/s-0043-118040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-118040</ArticleId><ArticleId IdType="pubmed">29139100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, et al. Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry. 2016;87:628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober P, Schwarte LA. Correlation coefficients: Appropriate use and interpretation. Anesth Analg. 2018 doi: 10.1213/ANE.0000000000002864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002864</ArticleId><ArticleId IdType="pubmed">29481436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2000 doi: 10.1164/ajrccm.161.1.9901057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.1.9901057</ArticleId><ArticleId IdType="pubmed">10619815</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: Early predictors of prolonged survival. J Neurol. 2006 doi: 10.1007/s00415-006-0226-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0226-8</ArticleId><ArticleId IdType="pubmed">16773270</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Bono V, Marchese S, La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: Clinical features and survival analysis. J Neurol Sci. 2012 doi: 10.1016/j.jns.2012.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.08.011</ArticleId><ArticleId IdType="pubmed">22989611</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>